Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hugo Calder"'
Publikováno v:
2022 IEEE Energy Conversion Congress and Exposition (ECCE).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::350d58acef831a2ade73d1d884e67247
https://doi.org/10.1109/ecce50734.2022.9947766
https://doi.org/10.1109/ecce50734.2022.9947766
Autor:
Irene Andreu-Saumell, Alba Rodriguez-Garcia, Vanessa Mühlgrabner, Marta Gimenez-Alejandre, Berta Marzal, Joan Castellsagué, Fara Brasó-Maristany, Hugo Calderon, Laura Angelats, Salut Colell, Mara Nuding, Marta Soria-Castellano, Paula Barbao, Aleix Prat, Alvaro Urbano-Ispizua, Johannes B. Huppa, Sonia Guedan
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Chimeric antigen receptor (CAR)-T cell therapy for solid tumors faces significant hurdles, including T-cell inhibition mediated by the PD-1/PD-L1 axis. The effects of disrupting this pathway on T-cells are being actively explored and controv
Externí odkaz:
https://doaj.org/article/7804df0598d54b5bb293efc2b4f633cf
Autor:
Natalia Egri, Hugo Calderón, Robert Martinez, Mario Vazquez, Verónica Gómez-Caverzaschi, Mariona Pascal, Olga Araújo, Manel Juan, Europa Azucena González-Navarro, José Hernández-Rodríguez
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundHumoral and cellular immune responses are known to be crucial for patients to recover from COVID-19 and to protect them against SARS-CoV-2 reinfection once infected or vaccinated.ObjectivesThis study aimed to investigate humoral and T cell
Externí odkaz:
https://doaj.org/article/fba262c9ad9740ea9f5441e5d4ea4dfc
Autor:
Natalia Egri, Victoria Olivé, José Hernández-Rodríguez, Pedro Castro, Catherine De Guzman, Libertad Heredia, Ana Castellet Segura, M. Dolores Fernandez, Noemi de Moner, María Torradeflot, Judit Ballús, Robert Martinez, Mario Vazquez, Marta Vidal Costa, Carlota Dobaño, Massimiliano Mazza, Lucia Mazzotti, Mariona Pascal, Manel Juan, Europa Azucena González-Navarro, Hugo Calderón
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cellular and humoral immune responses are essential for COVID-19 recovery and protection against SARS-CoV-2 reinfection. To date, the evaluation of SARS-CoV-2 immune protection has mainly focused on antibody detection, generally disregarding the cell
Externí odkaz:
https://doaj.org/article/e812613cd0b24345b15370c06f4a4ac4
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 12, Iss , Pp 145-156 (2019)
T cells engineered with chimeric antigen receptors (CARs) have emerged as a potent new class of therapeutics for cancer, based on their remarkable potency in blood cancers. Since the first clinical reports of their efficacy emerged 7 years ago, inves
Externí odkaz:
https://doaj.org/article/0040ed529c8846b3a3fe803c78f2835d
Autor:
Arthur Dyer, Ying Di, Hugo Calderon, Sam Illingworth, Gray Kueberuwa, Alison Tedcastle, Phil Jakeman, Suet Lin Chia, Alice Brown, Michael A. Silva, David Barlow, John Beadle, Terry Hermiston, David J.P. Ferguson, Brian Champion, Kerry D. Fisher, Leonard W. Seymour
Publikováno v:
Molecular Therapy: Oncolytics, Vol 4, Iss C, Pp 18-30 (2017)
Enadenotucirev (EnAd) is a chimeric group B adenovirus isolated by bioselection from a library of adenovirus serotypes. It replicates selectively in and kills a diverse range of carcinoma cells, shows effective anticancer activity in preclinical syst
Externí odkaz:
https://doaj.org/article/002ab69ebda84c369b82dc56d1ee6d03
Publikováno v:
Revista de Investigación, Desarrollo e Innovación, Vol 9, Iss 1 (2018)
El artículo presenta los resultados de un estudio de vigilancia tecnológica e inteligencia competitiva sobre la producción de tilapia roja (Oreochromis mossambicus), en el Departamento del Huila, Colombia. La investigación es cualitativa, descrip
Externí odkaz:
https://doaj.org/article/cf38ced5b28942aba192334eb6428de6
Autor:
Nalini Marino, Sam Illingworth, Prithvi Kodialbail, Ashvin Patel, Hugo Calderon, Rochelle Lear, Kerry D Fisher, Brian R Champion, Alice C N Brown
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177810 (2017)
Oncolytic viruses which infect and kill tumour cells can also be genetically modified to express therapeutic genes that augment their anti-cancer activities. Modifying oncolytic viruses to produce effective cancer therapies is challenging as encoding
Externí odkaz:
https://doaj.org/article/91f88a97391341e4b1e62c1a9d9294db
Autor:
Daouda Abba Moussa, Mario Vazquez, Christine Chable-Bessia, Vincent Roux-Portalez, Elia Tamagnini, Mattia Pedotti, Luca Simonelli, Giang Ngo, Manon Souchard, Sebastien Lyonnais, Myriam Chentouf, Nathalie Gros, Soledad Marsile-Medun, Heiko Dinter, Martine Pugnière, Pierre Martineau, Luca Varani, Manel Juan, Hugo Calderon, Mar Naranjo-Gomez, Mireia Pelegrin
Publikováno v:
Emerging Microbes and Infections, Vol 14, Iss 1 (2025)
Unlocking the potential of broadly reactive coronavirus monoclonal antibodies (mAbs) and their derivatives offers a transformative therapeutic avenue against severe COVID-19, especially crucial for safeguarding high-risk populations. Novel mAb-based
Externí odkaz:
https://doaj.org/article/adcce9f585fb4559a8b09e0bfdec259a